Multiplexed quantification of insulin and C-peptide by LC-MS/MS without the use of antibodies.
C-peptide
Insulin
LC-MS/MS
LC-MS/MS, liquid chromatography-tandem mass spectrometry
LLOQ, lower limit of quantitation
Liquid chromatography-tandem mass spectrometry
Plasma
Serum
TaMADOR, Targeted Mass Spectrometry Assays for Diabetes and Obesity Research
Journal
Journal of mass spectrometry and advances in the clinical lab
ISSN: 2667-145X
Titre abrégé: J Mass Spectrom Adv Clin Lab
Pays: Netherlands
ID NLM: 101776811
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
received:
11
04
2022
revised:
08
06
2022
accepted:
08
06
2022
entrez:
23
6
2022
pubmed:
24
6
2022
medline:
24
6
2022
Statut:
epublish
Résumé
The measurement of insulin and C-peptide provides a valuable tool for the clinical evaluation of hypoglycemia. In research, these biomarkers are used together to better understand hyperinsulinemia, hepatic insulin clearance, and beta cell function. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is an attractive approach for the analysis of insulin and C-peptide because the platform is specific, can avoid certain limitations of immunoassays, and can be multiplexed. Previously described LC-MS/MS methods for the simultaneous quantification of insulin and C-peptide measure the intact analytes and most have relied on immunoaffinity enrichment. These approaches can be limited in terms of sensitivity and interference from auto-antibodies, respectively. We have developed a novel method that does not require antibodies and uses proteolytic digestion to yield readily ionizable proteotypic peptides that enables the sensitive, specific, and simultaneous quantitation of insulin and C-peptide. Serum samples were precipitated with acetonitrile. Analytes were enriched using solid phase extraction and then digested with endoproteinase Glu-C. Surrogate peptides for insulin and C-peptide were analyzed using targeted LC-MS/MS. Inter-day imprecision was below 20 %CV and linearity was observed down to the lower limit of quantitation for both analytes (insulin = 0.09 ng/mL, C-peptide = 0.06 ng/mL). Comparison to a commercially available insulin immunoassay (Beckman Coulter UniCel DxI 600 Access) revealed a 30% bias between methods. A novel LC-MS/MS method for the simultaneous analysis of insulin and C-peptide using Glu-C digestion was developed and evaluated. A detailed standard operating procedure is provided to help facilitate implementation in other laboratories.
Identifiants
pubmed: 35734440
doi: 10.1016/j.jmsacl.2022.06.003
pii: S2667-145X(22)00018-9
pmc: PMC9207678
doi:
Types de publication
Journal Article
Langues
eng
Pagination
19-26Subventions
Organisme : NIDDK NIH HHS
ID : U01 DK121289
Pays : United States
Informations de copyright
© 2022 THE AUTHORS.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
J Am Board Fam Pract. 1999 Mar-Apr;12(2):133-6
pubmed: 10220236
Clin Kidney J. 2021 Feb 03;14(10):2255-2260
pubmed: 34603702
J Immunol Methods. 2000 Oct 20;244(1-2):91-103
pubmed: 11033022
Nature. 1988 May 5;333(6168):93-6
pubmed: 3283564
Clin Chem. 2013 Sep;59(9):1349-56
pubmed: 23709677
Clin Chim Acta. 1998 Jun 8;274(1):111-7
pubmed: 9681602
Ann Clin Biochem. 1999 Sep;36 ( Pt 5):541-64
pubmed: 10505204
Clin Chem. 2004 Jan;50(1):257-9
pubmed: 14709671
Mass Spectrom Rev. 2020 May;39(3):229-244
pubmed: 28691345
J Clin Endocrinol Metab. 2018 Oct 1;103(10):3845-3855
pubmed: 30085133
Anal Chem. 2005 Jun 1;77(11):3579-85
pubmed: 15924392
Anal Chem. 2014 Jan 7;86(1):694-702
pubmed: 24345052
Clin Lab. 2012;58(1-2):67-74
pubmed: 22372347
Analyst. 2019 Jul 21;144(14):4139-4148
pubmed: 31143899
Endocr Pract. 2015 Oct;21(10):1093-7
pubmed: 26121452
J Mass Spectrom Adv Clin Lab. 2021 Jan;19:1-6
pubmed: 34723236
J Clin Invest. 1978 Jul;62(1):197-203
pubmed: 659633
J Biol Chem. 1997 May 9;272(19):12513-22
pubmed: 9139702
Clin Chem Lab Med. 2002 Jul;40(7):705-8
pubmed: 12241018
Drug Test Anal. 2020 Mar;12(3):382-390
pubmed: 31930697
Clin Chem. 2018 Feb;64(2):408-410
pubmed: 29203474
Endocr Rev. 1998 Oct;19(5):608-24
pubmed: 9793760
Curr Med Res Opin. 2003;19(1):34-40
pubmed: 12661778
Ann Clin Biochem. 2015 May;52(Pt 3):312-8
pubmed: 25172526
Eur J Clin Chem Clin Biochem. 1997 May;35(5):365-7
pubmed: 9189740
Clin Chim Acta. 2016 Apr 1;455:202-8
pubmed: 26820765
Diabetes Care. 2010 Jan;33(1):205-6
pubmed: 20040676
Clin Chem. 2007 Apr;53(4):711-6
pubmed: 17272483
Pediatrics. 1998 Dec;102(6):1401-6
pubmed: 9832576
Clin Biochem. 2014 Apr;47(6):445-7
pubmed: 24486652